Stable Patients With Atherosclerotic Renal Artery Stenosis Should Be Treated First With Medical Management: Pro

American Journal of Kidney Diseases

Volumn 42, Issue 5, 2003, Pages 851-857

  Plouin, Pierre François ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOSARTAN; RAMIPRIL; STATINE DERIVATIVE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DISEASE COURSE; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVASCULARIZATION; REVIEW;

EID: 0142219937     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajkd.2003.08.006     Document Type: Article

References (42)

1. Rimmer JM, Gennari FJ: Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 118: 712-719, 1993
2. Conlon PJ, Little MA, Piper K, Mark DB: Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 60:1490-1497, 2001
3. Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P: Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 17:1743-1750, 1999
4. Uzu T, Inoue T, Fujii T, et al: Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis 29:733-738, 1997
5. Kuroda S, Nishida N, Uzu T, et al: Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke 31:61-65, 2000
6. Swartbol P, Thorvinger BOT, Parsson H, Norgren L: Renal artery stenosis in patients with peripheral vascular disease and its correlation with hypertension. Int Angiol 11:195-199, 1992
7. Bloch MJ, Trost DW, Pickering TG, Sos TA, August P: Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement. Am J Hypertens 12:1-7, 1999
8. Connolly JO, Higgins RM, Walters HL, et al: Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. QJM 87:413-21, 1994
9. Textor SC, Wilcox CS: Renal artery stenosis: A common, treatable cause of renal failure? Annu Rev Med 52:421-442, 2001
10. Plouin PF, Rossignol P, Bobrie G: Atherosclerotic renal artery stenosis: To treat conservatively, to dilate, to stent or to operate? J Am Soc Nephrol 12:2190-2196, 2001
11. van de Ven PJ, Beutler JJ, Kaatee R, Beek FJ, Mali WP, Koomans HA: Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int 53:986-993, 1998
12. Textor SC, Novick AC, Tarazi RC, Klimas V, Vidt DG, Pohl M: Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease. Ann Intern Med 102:308-314, 1985
13. Simon G: What is critical renal artery stenosis? Implications for treatment. Am J Hypertens 13:1189-1193, 2000
14. van Jaarsveld BC, Krijnen P, Pieterman H, et al: The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 342: 1007-1014, 2000
15. van de Ven PJ, Kaatee R, Beutler JJ, et al: Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomised trial. Lancet 353:282-286, 1999
16. van Jaarsveld BC, Pieterman H, van Dijk LC, et al: Inter-observer variability in the angiographic assessment of renal artery stenosis. J Hypertens 17:1731-1736, 1999
17. Caps MT, Perissinotto C, Zierler RE, et al: Prospective study of atherosclerotic disease progression in the renal artery. Circulation 98:2866-2872, 1998
18. Caps MT, Zierler RE, Polissar NL, et al: Prospective study of atherosclerotic disease progression in the renal artery. Kidney Int 53:735-742, 1998
19. Conlon PJ, O'Riordan E, Kalra PA: New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular disease. Am J Kidney Dis 35:573-587, 2000
20. Radermacher J, Chavan A, Bleck J, et al: Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 344:410-417, 2001
21. Radermacher J, Weinkove R, Haller H: Techniques for predicting a favourable response to renal angioplasty in patients with renovascular disease. Curr Opin Nephrol Hypertens 10:799-805, 2001
22. Kennedy DJ, Colyer WR, Brewster PS, et al: Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis 42:926-935, 2003
23. Fried LP, Kronmal RA, Newman AB, et al: Risk factors for 5-year mortality in older adults: The Cardiovascular Health Study. JAMA 279:585-592, 1998
24. Szczech LA, Best PJ, Crowley E, et al: Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation 105:2253-2258, 2002
25. Landray MJ, Thambyrajah J, McGlynn FJ, et al: Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 38:537-546, 2001
26. Murphy TP, Rundback JH, Cooper C, Kiernan MS: Chronic renal ischemia: Implications for cardiovascular disease risk. J Vasc Interv Radiol 13:1187-1198, 2002
27. Staessen JA, Wang JG, Thijs L: Cardiovascular prevention and blood pressure reduction: A quantitative overview updated until 1 March 2003. J Hypertens 21:1055-1076, 2003
28. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71-86, 2002
29. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360:7-22, 2002
30. Chobanian AV, Bakris GL, Black HR, et al: The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 289:2560-2572, 2003
31. The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342:145-153, 2000
32. Ruggenenti P, Perna A, Gherardi G, et al: Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354:359-364, 1999
33. Dahlof B, Devereux RB, Kjeldsen SE, et al: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 359:995-1003, 2002
34. Brenner BM, Cooper ME, de Zeeuw D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
35. Weibull H, Bergqvist D, Bergentz SE, Jonsson K, Hulthén UL, Manhem P: Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: A prospective randomized study. J Vasc Surg 18:841-852, 1993
36. Leertouwer TC, Gussenhoven EJ, Bosch JL, et al: Stent placement for renal arterial stenosis: Where do we stand? A meta-analysis. Radiology 216:78-85, 2000
37. Plouin PF, Darné B, Chatellier G, et al: Restenosis after a first percutaneous transluminal renal angioplasty. Hypertension 21:89-96, 1993
38. Plouin PF, Chatellier G, Darne B, Raynaud A: Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 31:823-829, 1998
39. Webster J, Marshall F, Abdalla M, et al: Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 12:329-335, 1998
40. Ives NJ, Wheatley K, Stowe RL, et al: Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: A meta-analysis of randomized trials. Nephrol Dial Transplant 18:298-304, 2003
41. Muray S, Martin M, Amoedo ML, et al: Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis 39:60-66, 2002
42. Streeten DHP, Anderson GH, Wagner S: Effect of age on response of secondary hypertension to specific treatment. Am J Hypertens 3:360-365, 1990